Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer
about
PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunologyProgrammed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.
P2860
Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Antagonizing programmed death- ...... ic approach for gastric cancer
@ast
Antagonizing programmed death- ...... ic approach for gastric cancer
@en
Antagonizing programmed death- ...... ic approach for gastric cancer
@nl
type
label
Antagonizing programmed death- ...... ic approach for gastric cancer
@ast
Antagonizing programmed death- ...... ic approach for gastric cancer
@en
Antagonizing programmed death- ...... ic approach for gastric cancer
@nl
prefLabel
Antagonizing programmed death- ...... ic approach for gastric cancer
@ast
Antagonizing programmed death- ...... ic approach for gastric cancer
@en
Antagonizing programmed death- ...... ic approach for gastric cancer
@nl
P2093
P2860
P3181
P356
P1476
Antagonizing programmed death- ...... ic approach for gastric cancer
@en
P2093
P2860
P304
P3181
P356
10.1177/1756283X16658251
P407
P577
2016-11-01T00:00:00Z